By Sharon AtienoKenya risks a vaccination crisis if the country does not honour its Global Alliance for Vaccines and ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...

A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

The United Nations International Children’s Emergency Fund (Unicef) has warned that funding cuts from donor countries will ...

A dividend from immunisation is a future free from the diseases that rob communities of health and well-being, a future free ...

ImmunityBio (IBRX) faces operational, financial, and competitive challenges, impacting its growth prospects despite Anktiva's ...

Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...

In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited marked ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...